Acute effect of captopril on aldosterone secretory responses to endogenous or exogenous adrenocorticotropin.
The aldosterone secretory response to Captopril (12.5 mg, orally) was studied in five normal men. Endogenous ACTH and epinephrine secretion was stimulated by the induction of hypoglycemia. Normally this stimulus increases plasma cortisol, GH, aldosterone, and PRA. Administration of captopril resulted in a blunted plasma aldosterone response to hypoglycemia, but no concomitant blunting of the plasma cortisol response. The responses of other hormones, with the exception of PRA, were not affected. When exogenous ACTH was administered to the same men with and without captopril, the plasma aldosterone response was again blunted by captopril, while the plasma cortisol response was unaffected. We conclude that angiotensin II may be required for ACTH to stimulate aldosterone secretion. Alternatively, the possibility that captopril may selectively inhibit aldosterone secretion at the adrenal cellular level cannot be excluded.
Ramirez
G
G
Department of Internal Medicine, James A. Haley Veterans Administration Hospital, Tampa, Florida 33612.
Ganguly
A
A
Brueggemeyer
C D
CD
D000324:Adrenocorticotropic Hormone / Q000502:physiology*; D000328:Adult; D000450:Aldosterone / Q000378:metabolism*; D001786:Blood Glucose / Q000378:metabolism; D002216:Captopril / Q000494:pharmacology*; D004837:Epinephrine / Q000097:blood; D013006:Growth Hormone / Q000097:blood; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D007328:Insulin; D007700:Kinetics; D008297:Male; D011188:Potassium / Q000097:blood; D012083:Renin / Q000097:blood
D001786:Blood Glucose; D007328:Insulin; D000450:Aldosterone; D000324:Adrenocorticotropic Hormone; D013006:Growth Hormone; D002216:Captopril; D012083:Renin; D011188:Potassium; D006854:Hydrocortisone; D004837:Epinephrine